What is Nektar Therapeutics's equity method income?

Nektar Therapeutics (NKTR) reported equity method income of -$1.75M in Q1 2026.

How has Nektar Therapeutics's equity method income changed year-over-year?

Nektar Therapeutics's equity method income increased by 60.8% year-over-year, from -$4.46M to -$1.75M.

What does equity method income mean?

The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Nektar Therapeutics NKTR Equity Method Income

Equity Method Income at other companies

Cabot CorporationCBT

$2M-33.3%

HES

Hess MidstreamHESM

$3.2M-5.9%

American Healthcare REITAHR

$792K+143%

Liberty Broadband CorporationLBRDK

$308M-3.1%

Atmus Filtration TechnologiesATMU

$7.6M-17.4%

Kinetik HoldingsKNTK

$51.19M-10.9%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.19B+1,531%

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's equity method income?: Nektar Therapeutics (NKTR) reported equity method income of -$1.75M in Q1 2026.
How has Nektar Therapeutics's equity method income changed year-over-year?: Nektar Therapeutics's equity method income increased by 60.8% year-over-year, from -$4.46M to -$1.75M.
What does equity method income mean?: The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.